American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of common stock in Trimas Corporation as of September 30, 2026.

Key Highlights

  • Three reporting persons: American Century Investment Management, Inc. (investment adviser), American Century Companies, Inc. (holding company), and Stowers Institute for Medical Research (holding company) each report identical aggregate positions.
  • Shares beneficially owned: Each reporting person lists 1,862,684 shares of Trimas Corporation common stock.
  • Percent of class: The 1,862,684 shares represent 5.2% of the outstanding class, according to the filing.
  • Voting and dispositive power: Each reporting person reports sole voting power and sole dispositive power over all 1,862,684 shares, with zero shared voting or dispositive power.
  • Event date: The date of the event requiring the filing is listed as September 30, 2026.
  • Corporate structure: The filing states that American Century Investment Management, Inc. is a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.

American Century's Disclosed Position in Trimas Corporation Common Stock

According to the Schedule 13G filed jointly on November 16, 2026, American Century Investment Management, Inc. ("ACIM"), American Century Companies, Inc. ("ACC"), and Stowers Institute for Medical Research each report beneficial ownership of 1,862,684 shares of Trimas Corporation common stock, representing 5.2% of the class. The triggering event date is listed as September 30, 2026. The filing identifies ACIM as an investment adviser (type "IA") and both ACC and Stowers Institute as holding companies (type "HC").

The filing states that ACIM "is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940," and that ACC is controlled by the Stowers Institute for Medical Research. Each of the three reporting persons reports 1,862,684 shares in sole voting power and 1,862,684 shares in sole dispositive power, with no shared voting or dispositive power reported for any of them.

Regarding the source of the reported holdings, the filing discloses that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filing further states that no single client advised by ACIM owns more than 5% of the class. The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

A Schedule 13G was filed jointly by American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research, disclosing aggregate beneficial ownership of 1,862,684 shares, or 5.2%, of Trimas Corporation common stock as of September 30, 2026.